Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 9
Multidimensional Role of Amino Acid Metabolism in Immune Regulation: From Molecular Mechanisms to Therapeutic Strategies
Chen Qin, Guanqing Yang, Wei Qi, et al.
Chemical Research in Chinese Universities (2024)
Closed Access | Times Cited: 4
Research Progress on the Therapeutic Mechanisms of Stigmasterol for Multiple Diseases
Juan Li, Xinhua Zheng, Jinxu Qi
Molecules (2025) Vol. 30, Iss. 9, pp. 1874-1874
Open Access
Metabolomics analyses reveal the crucial role of ERK in regulating metabolic pathways associated with the proliferation of human cutaneous T‐cell lymphoma cells treated with Glabridin
Abdul Q. Khan, Maha Victor Agha, Fareed Ahmad, et al.
Cell Proliferation (2024) Vol. 57, Iss. 9
Open Access | Times Cited: 3
NK/DC crosstalk-modulating antitumor activity via Sema3E/PlexinD1 axis for enhanced cancer immunotherapy
Awais Ali, Abdulaziz Alamri, Azraida Hajar
Immunologic Research (2024)
Closed Access | Times Cited: 3
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
Xuetong Shen, Chundi Gao, Huayao Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Effect of autologous dendritic cell cytokine-induced killer on refractory metastatic colorectal cancer: a matched case–control comparative study
Sheng‐Chi Chang, Tao‐Wei Ke, William Tzu‐Liang Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer receiving first‐line immunotherapy
Xixi Zheng, Lili Zhou, Hui Shi, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 28, pp. 2029-2037
Open Access | Times Cited: 1
Advancements in conventional cancer therapy combined with immunotherapy
Hongxia Li, Songyan Han, Chunbo Dong, et al.
Oncology and Translational Medicine (2024) Vol. 11, Iss. 1, pp. 17-28
Open Access | Times Cited: 1
DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma
Yu Du, Heng Li, Yan Wang, et al.
PeerJ (2024) Vol. 12, pp. e16823-e16823
Open Access
Page 1

Scroll to top